FLETCHER MARK 4
4 · GENEREX BIOTECHNOLOGY CORP · Filed Oct 15, 2018
Insider Transaction Report
Form 4
FLETCHER MARK
EVP & General Counsel
Transactions
- Award
Stock Option (right to buy)
2018-10-03+4,500→ 4,500 totalExercise: $2.23Exp: 2028-10-03→ Common Stock (4,500 underlying)
Holdings
- 15,625
Common Stock
Footnotes (1)
- [F1]The option vests in three equal annual installments beginning on October 3, 2018.